Results 301 to 309 of about 192,885 (309)

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

New England Journal of Medicine, 2018
Hope S Rugo, CARLOS H Barrios, Hiroji Iwata   +2 more
exaly  

Triple-negative breast cancer: disease entity or title of convenience?

Nature Reviews Clinical Oncology, 2010
Lisa A Carey, Eric P Winer, Giuseppe Viale   +2 more
exaly  

Pembrolizumab for triple-negative breast cancer

The Lancet Oncology, 2020
openaire   +2 more sources

Platinum-based chemotherapy in triple-negative breast cancer

Annals of Oncology, 2008
B Sirohi, M Arnedos, Sanjay Popat
exaly  

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

New England Journal of Medicine, 2019
Aditya Bardia, Íngrid A Mayer, Linda T Vahdat   +2 more
exaly  

Survival among women with triple receptor-negative breast cancer and brain metastases

Annals of Oncology, 2009
F J Esteva, C Albarracin, G N Hortobagyi   +2 more
exaly  

MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition

Journal of Experimental Medicine, 2012
Dai Horiuchi, Sanjay Chandriani, Marc E Lenburg   +2 more
exaly  

Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event‐free and overall survival benefits in premenopausal women with triple‐negative breast cancer

Ca-A Cancer Journal for Clinicians
exaly  

Triple-negative breast cancer fly

Lab Animal
openaire   +2 more sources